The drama swirling around Delve, the compliance startup once praised for its promise, has deepened this week into something like a full-blown inferno. The fuel for this latest outburst? Fresh accusations raised by an anonymous insider, known online as DeepDelver, who claims Delve quietly took an open-source technology and rebranded it—without crediting, let alone paying, the original creators.
It started with a tool Delve called Pathways. In a pitch to a potential client—a person who, in an odd twist, would become DeepDelver—the Delve team showcased Pathways as a no-code solution. But DeepDelver wasn’t just any prospect; something about Pathways rang a bell, and suspicion tugged at their sleeve. The interface looked uncomfortably familiar. It bore a striking resemblance to SimStudio, a free agent-building framework distributed under the permissive Apache license by a company called Sim.ai.
DeepDelver confronted Delve directly: was Pathways based on SimStudio? According to the whistleblower, Delve denied it. Built in-house, they insisted. End of story, or so they hoped.
But DeepDelver wasn’t satisfied. They dug deeper and surfaced what they called evidence—lines of code altered just enough to mask their origins, yet still unmistakably linked to SimStudio. If this evidence stands, Delve’s “homemade” tool was little more than a fork dressed up in a new skin. Such a move isn’t just a breach of professional ethics; it would directly violate the Apache license, which doesn’t forbid commercial use but does demand proper attribution.
In private messages, DeepDelver used words like “theft” and “intellectual property,” perhaps leaning into the rhetoric. Open source, after all, is meant to be shared, but it’s also meant to be credited. The irony cuts deep: a compliance startup, built on the pitch of helping others follow rules, now accused of flouting them.
Sim.ai’s founder and CEO, Emir Karabeg, confirmed that he’d been in contact with DeepDelver about these rumors. He told the whistleblower—point blank—that Delve had never struck any kind of licensing agreement with Sim.ai. “We always knew they were interested,” Karabeg admitted, recalling an attempt to negotiate a contract that ultimately fizzled. “But I had no idea they planned to take it off the shelf and repackage it as their own.”
The whole affair gets stranger still. Sim.ai isn’t just a competitor; it’s also a Delve customer. Both companies cut their teeth at Y Combinator, that hothouse of ambitious tech founders. YC grads often support each other’s projects. In this case, though, the relationship feels rather one-sided: Sim.ai paid Delve, but the reverse never happened.
Karabeg’s own emotions in this debacle seem genuine. Last week, when DeepDelver first went public with unrelated claims—that Delve exaggerated customer data and used lenient auditors—Karabeg actually empathized with his former colleagues. But after these new claims surfaced, he says, they’ve gone quiet. “I reached out after the initial allegations to offer support,” he told TechCrunch. “Since hearing about this, I haven’t heard a word.”
Meanwhile, Delve’s silence has grown louder. References to Pathways are vanishing from their website. Pages disappear. Even their press contact address reportedly no longer works. Requests for comment? Unanswered.
There’s also an uncomfortable question looming for Insight Partners, the heavyweight VC that led Delve’s Series A. According to DeepDelver, these events predate the $32 million fundraising round. When asked, neither Delve nor their investors offered any explanation. Adding to the mystery, Insight’s official blog post lauding the deal was briefly unavailable. Their celebratory LinkedIn post? Still missing as of today.
The story has become a lightning rod online. On X, the chatter about Delve’s questionable license practices has gone viral, amplified by community notes and heated replies. The startup world, always quick to judge, is watching closely.
At its heart, the scandal is raw and unresolved: a company founded on trust now stands accused of betraying that very ideal—not just with a rival, but with an ally who once believed in them. Whether Delve can weather this depends on what’s proven true, and how they—or their investors—choose to respond. For now, the silence feels damning.
